Answer:
Where are the pictures? I would like to help you.
Every institution will set a minimum qualifying score for CLEP exams. If you reach the required score, the institution will determine the credits it will award the student. The two sample scenarios where this may happen: Find out what credits can be earned, and other factors that may affect the test, the results and credit.
TRANSCEND CLL 004 is a clinical trial that assesses a type of CAR T-cell therapy in patients suffering relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
<h3>What is CAR T-cell therapy?</h3>
The chimeric antigen receptor (CAR) T-cell therapy is a gene therapy based on genetic engineering to produce T cells that are able to target specific antigens.
The chimeric antigen receptor (CAR) T-cell therapy may result very useful to kill specific cancer cells.
In conclusion, TRANSCEND CLL 004 is a clinical trial that assesses a type of CAR T-cell therapy in patients suffering relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Learn more about gene therapy here:
brainly.com/question/315648
#SPJ1
